Get started
Author

Ningning Luo

Observed name: Luo, Ningning
ORCID: 0000-0002-1991-1168
Observed ORCID: 0000-0002-1991-1168
OpenAlex ID: A5108939067
Successful treatment of advanced pulmonary sarcomatoid carcinoma with the PD-1 inhibitor toripalimab: A case report
2020 · Yuyan Jiao, Ming Liu, et al. · Oral Oncology · 28
Clinical efficacy and biomarker analysis of neoadjuvant camrelizumab plus chemotherapy for early-stage triple-negative breast cancer: a experimental single-arm phase II clinical trial pilot study
2023 · Chunhui Zheng, Yanbing Liu, et al. · International Journal of Surgery · 23
The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer
2022 · Yong Wang, Ningning Luo, et al. · Journal of Cancer Research and Clinical Oncology · 17
Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma
2024 · Ying Lu, Zhouyu Wang, et al. · Cellular and Molecular Neurobiology · 14
PDF
A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report
2020 · Yanwei Sun, Lina Pei, et al. · OncoTargets and Therapy · 14
PDF
Transformation of invasive lung adenocarcinoma with ALK rearrangement into pulmonary sarcomatoid carcinoma
2022 · Xianjin Xie, Xudong Chen, et al. · Journal of Cancer Research and Clinical Oncology · 11
Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma
2022 · Peng Li, Shuyu Che, et al. · Journal of Cancer Research and Clinical Oncology · 10
Almonertinib Combined with Anlotinib and Temozolomide in a Patient with Recurrent Glioblastoma with EGFR L858R Mutation
2023 · Zhiwei Hou, Huaguo Wu, et al. · The Oncologist · 7
Predictive value of ZFHX4 mutation for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer and melanoma
2024 · Cong Fu, Haoran Gu, et al. · Investigational New Drugs · 6
Genetic and clinical characteristics of genetic tumor syndromes in the central nervous system cancers: Implications for clinical practice
2024 · Chuanwei Wang, Jian Chen, et al. · iScience · 6
Afatinib, an effective treatment for patient with lung squamous cell carcinoma harboring uncommon EGFR G719A and R776C co-mutations
2022 · Chao Han, Xuan Ding, et al. · Journal of Cancer Research and Clinical Oncology · 6
The First Case Report of a Patient With Oligodendroglioma Harboring CHEK2 Germline Mutation
2022 · Xueen Li, Hao Xue, et al. · Frontiers in Genetics · 6
PDF
Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms
2025 · Hainan Li, Ningning Luo, et al. · BMC Cancer · 5
PDF
Molecular genomic landscape of pediatric solid tumors in Chinese patients: implications for clinical significance
2023 · Gang Li, Jie Gong, et al. · Journal of Cancer Research and Clinical Oncology · 5
PDF
Successful treatment of an adult patient with diffuse midline glioma employing olaparib combined with bevacizumab
2021 · Yong Wang, Jun Xu, et al. · Investigational New Drugs · 5
PDF
EGFR L861Q and CDK4 amplification responding to afatinib combined with palbociclib treatment in a patient with advanced lung squamous cell carcinoma
2020 · Hui Jiang, Ningning Luo, et al. · Lung Cancer · 5
Clinical and genomic features of Lynch syndrome differ by tumor site and disease spectrum
2025 · Shisen Li, Ningning Luo, et al. · Nature Communications · 4
PDF
A novel NECTIN4-NTRK1 fusion identified in a lung squamous cell carcinoma patient with MSI-H
2021 · Peng Li, Feng Hou, et al. · Journal of Cancer Research and Clinical Oncology · 4
A case report of a patient with first phenotype of papillary thyroid carcinoma and heterochronous multiprimary tumor harboring germline MUTYH Arg19*/Gly286Glu mutations
2020 · Mingbo Wang, Fuxin Zhu, et al. · Oral Oncology · 4
Novel MRPL13-ALK and PPP1CB-ALK Double Fusion As a Potential Mechanism of Acquired Resistance to First-Line Osimertinib in EGFR-Mutant High-Grade Neuroendocrine Tumor of the Lung
2020 · Yuyan Jiao, Ming Liu, et al. · JTO Clinical and Research Reports · 4
PDF
Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome
2024 · Haiping Zhang, Wuping Wang, et al. · World Journal of Surgical Oncology · 3
Assessment of CDKN2A homozygous and hemizygous deletion status in gliomas.
2024 · Hainan Li, Chongzhu Fan, et al. · Journal of Clinical Oncology · 2
A Novel Germline SDHA Gene Mutation and Co-Occurring Somatic KIT Activating Mutation in a Patient With Pediatric Central Nervous System Germ Cell Tumor: Case Report
2022 · Xizan Yue, Bo Liu, et al. · Frontiers in Oncology · 2
PDF
Effective treatment in lung adenocarcinoma patient with brain metastases harboring novel CLHC1/RNT4 intergenic region- ALK fusion
2022 · Huanling Xia, Binbin Liang, et al. · Medicine · 2
A novel KLHL6/KLHL24 intergenic region-NTRK3 fusion in a patient with lung squamous cell carcinoma
2021 · Donghua Zhao, Feng Hou, et al. · Lung Cancer · 2
Works count: 68
Citation count: 207
H-index: 7
I10-index: 7
Year
Topic
Type